WTO Quantitative Restrictions

European Union #5826 (v.1)

Base data

Notified in
Version validity
13/04/2020 - present
Current active version v.1
Reporting member
European Union
In force from
End date
In force
General description
Greece: Export prohibition of medicinal products
National legal basis
Decisions from the Ministry of Health, all adopted on 13 April 2020:

No 43196 (concerning vaccines)

https://www.eof.gr/c/document_library/get_file?uuid=e9749853-3c85-4a85-a380-9ebe174e1c35&groupId=12225

No 43197 (concerning pharmaceutical products potentially in shortage due to Covid-19)

https://www.eof.gr/c/document_library/get_file?uuid=b4f8f46f-9168-48c8-a3e6-c6d01cd5c360&groupId=12225

List of products:

https://www.eof.gr/c/document_library/get_file?uuid=c90c8cfe-d2c8-497b-9f81-2b6f84da6096&groupId=12225

No 43198 (concerning pharmaceutical products in shortage)

https://www.eof.gr/c/document_library/get_file?uuid=96aca85a-4551-4d66-8063-540e4ad09517&groupId=12225

List of products:

https://www.eof.gr/c/document_library/get_file?uuid=426a5298-e17f-4fba-a951-b282414b5736&groupId=12225
Administrative mechanism
Republic of Greece, Ministry of Health

The measures are temporary
Responsible entities
HS version
HS 2017
Referenced WTO document symbol

Meta data

WTO justifications

No specific provision provided

No specific provision provided

Reported as: Protection of human life or health, inter alia
Non-WTO commitments
Affected partners
Non-affected partners

Measures

Reported restrictions
P-X
Symbol
P-X

Tariff lines
NA
Vaccines and medicines that are or might be in shortage due to the Covid-19 pandemic For details, pl...